Seroprevalence of bovine viral diarrhoea virus in Hungary — situation before launching an eradication campaign

Seroprevalence of bovine viral diarrhoea virus in Hungary - situation before launching an eradication campaign.

Bovine viral diarrhoea (BVD) is a viral disease appearing in various forms and causing high economic losses in the cattle stocks of Hungary. The aim of the present study was to determine the prevalence of bovine viral diarrhoea virus (BVDV) in Hungary through a monitoring survey carried out on samples collected in cattle-keeping units throughout the country. Since no such survey had been carrie...

Economic Impacts, Control and Eradication of Bovine Viral Diarrhoea Virus

Infections with Bovine Viral Diarrhoea Virus (BVD) are endemic in cattle populations worldwide and result in major economic losses; hence, many countries have begun BVD eradication programs. The authors estimated the losses caused by BVD, and the estimated annual losses in 2012 amounted to 4.5 million EUR in Hungary. In a dairy cattle farm with 1000 cows the acute clinical BVD could cause more ...

Bovine Viral Diarrhea Virus Control and Eradication

BVDV is estimated to cost an average dairy between $20 and $160 per adult cow per year. These losses include medication and labor to treat acute infections, milk production losses in lactating cows, infertility due to decreased conception and early embryonic death, abortions, loss of weak, abnormal, or persistently infected calves. Large scale herd outbreaks such as occurred in the early 1990s ...

The occurrence of bovine virus diarrhoea/muscosal disease in Iran

Prevalence of bovine viral diarrhoea virus antibodies in India.

A study was undertaken regarding the prevalence of bovine viral diarrhoea virus (BVDV) antibodies in bovine sera which tested negative for rinderpest and peste des petits ruminants virus antibodies. The samples were collected between January 1996 and December 1997. A total of 439 samples (327 cattle and 112 buffalo from 17 states of India) were tested using a commercial enzyme-linked immunosorb...